US Edition
Kilitch Drugs to raise around ₹50 crore via rights issue at Rs. 375 per share - Express Pharma
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Kilitch Drugs to raise around ₹50 crore via rights issue at Rs. 375 per share - Express Pharma
Kilitch Drugs, a pharmaceutical company specialising in the manufacturing and distribution of high-quality Parenteral, Injectables, Oral Solids, and Effervescent formulations, has received approval from the board to raise around ₹49.92 crore via a rights issue. In its board meeting, the Board of Directors finalised the Rights Issue of 13,98,463 fully paid-up equity shares of face value ₹10/- each at an issue price of ₹357/- per share (including …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
